4
Changes in Ownership
X4 Pharmaceuticals, Inc Filed Acc 0001628280-24-010278
Chief Operating Officer sold 15,409 shares at $0.88 ($13,591)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| DiBiase Mary Chief Operating Officer | 2024-03-11 | Sale | −15,409 | $0.88 | $13,591 | 291,752 | D |
| Open-market sales · 15,409 sh · avg $0.88 · $13,591 | |||||||
Loading xslF345X05/wk-form4_1710191967.xml…